期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
送餐入户方案治疗有症状腹水的前瞻性对照研究的设计与合理性:SALTYFOOD试验
1
作者 Elliot B.Tapper Jad Baki +1 位作者 scott hummel Anna Lok 《Gastroenterology Report》 SCIE EI 2019年第2期146-149,I0002,共5页
Background:When patients with cirrhosis develop ascites,it is associated with sharply increasedmortality and healthcare utilization with decreased quality of life.Dietary salt restriction is first-line therapy for asc... Background:When patients with cirrhosis develop ascites,it is associated with sharply increasedmortality and healthcare utilization with decreased quality of life.Dietary salt restriction is first-line therapy for ascites but it is limited by poor adherence.Methods:We will recruit 40 patients with cirrhosis and ascites who have received a recent paracentesis or hospitalization for a 1:1 randomized trial of standard care(education on salt restriction)versus home-delivered meals.Our primary outcome is the number of paracenteses needed over 12 weeks.Secondary outcomes include hospital-bed days,health-related quality of life(HRQOL,Ascites Symptom Inventory-7 and Visual Analogue Scale)and performance on batteries of physical function including hand grip(kg)and walk speed(m/s).All subjects follow up through a series of calls where any paracenteses,hospital readmissions,weight changes and diuretic dosage changes are recorded.In a final Week 12 visit,knowledge of dietary sodium intake,quality of life and frailty are reassessed,and satisfaction with the meal-delivery program is evaluated.Paired comparison testing will be conducted between the two arms.Discussion:A nutritionally standardized meal-delivery program for patients with cirrhosis and ascites post discharge has a variety of potential patient-based benefits,including the effective management of ascites,reduction of healthcare utilization and improvement of HRQOL.We have three core hypotheses.First,patients will report interest in and satisfaction with a home-delivered meals program.Second,subjects on a salt-restricted(2 g sodium)meal-delivery program will have fewer therapeutic paracenteses and all-cause readmissions than subjects receiving standard of care.Third,subjects on a saltrestricted(2 g sodium)meal-delivery program will report increased HRQOL compared to subjects receiving standard of care. 展开更多
关键词 READMISSIONS MALNUTRITION CIRRHOSIS NUTRITION sodium
原文传递
医学定制配餐治疗有症状的腹水:SALTYFOOD随机对照临床预试验
2
作者 Elliot B.Tapper Jad Baki +3 位作者 Samantha Nikirk scott hummel Sumeet K.Asrani Anna SLok 《Gastroenterology Report》 SCIE EI 2020年第6期453-456,I0002,共5页
背景:腹水是一种处理起来费时费力的肝硬化并发症。尽管低盐饮食是临床上治疗腹水的核心,但其疗效受限于患者的低依从性。我们旨在评估一种低盐的医学定制配餐(MTM)用于腹水治疗的可行性及疗效。方法:前瞻性纳入40例肝硬化腹水患者进行... 背景:腹水是一种处理起来费时费力的肝硬化并发症。尽管低盐饮食是临床上治疗腹水的核心,但其疗效受限于患者的低依从性。我们旨在评估一种低盐的医学定制配餐(MTM)用于腹水治疗的可行性及疗效。方法:前瞻性纳入40例肝硬化腹水患者进行一个为期12周的1:1随机对照预试验,接受标准治疗(SOC)的患者遵照低盐饮食教育手册自由饮食;MTM组患者的配餐中,盐<2000 mg,热量>2100 kcal,蛋白质≥80 g。我们测算了入组患者的比例及其对MTM的依从性。本研究的主要结局指标是12周内穿刺抽水的次数,同时,我们还记录了腹水特异性生活质量(ASI-7)评分。结果:入组病例的中位年龄为54(IQR:47-63)岁,46%是女性,中位MELD-Na评分为18(IQR:11-23),中位白蛋白水平2.7(IQR:2.5-3.3)g/dL。作为基线资料,研究开始前4周内,患者接受穿刺抽水的中位次数为2(IQR:1-3)。入组病例住院期间对于配餐计划的依从性良好。12周后,MTM组患者每周所需的穿刺抽水次数显著低于SOC组[中位数(IQR):0.34(0.14-0.54)vs 0.45(0.25-0.64)]。研究期间,4例(20%)SOC组患者死亡,MTM组中2例死亡,1例行肝移植术。腹水特异性生活质量改善程度MTM组优于SOC组,分别为25%(IQR:-11%-61%)和13%(IQR:-28%-54%)。结论:对于腹水患者开展MTM临床试验是可行的,也是潜在有效的。两组患者都有获益,需要强调的是,该研究挑战性高,需加强宣教和密切监测。 展开更多
关键词 CIRRHOSIS ASCITES PARACENTESIS SODIUM
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部